The infectious diseases diagnostics market is expected to witness significant growth in 2022 due to the increasing prevalence of infectious diseases, the growing focus on early diagnosis and treatment, and the availability of advanced diagnostic technologies. Infectious diseases diagnostics involve the detection and identification of infectious agents, such as bacteria, viruses, fungi, and parasites, in order to guide the treatment and management of infectious diseases. The growing demand for rapid and accurate diagnostic tests, the increasing research and development activities in the field of infectious diseases, and the availability of advanced diagnostic technologies, such as molecular diagnostics, are expected to drive the growth of the market. In addition, the growing focus on the development of point-of-care diagnostic tests and the increasing adoption of these tests are also contributing to the growth of the market.
Request For Free Sample Report of “Infectious Diseases Diagnostics Market”@ https://www.persistencemarketresearch.com/samples/11413
According to the latest market report published by Persistence Market Research, titled “Global Market Study on Infectious Diseases Diagnostics: Increasing Demand for Evidence-Based Treatment to Boost Demand for Infectious Diagnostic Testing during Forecast Period”. The global market for infectious diseases diagnostics is estimated to reach US$ 876.6 Mn in 2016 from US$ 827.7 Mn in 2015 owing to increasing demand for diagnostic kits caused by rising incidence rate of infectious diseases.
The global infectious disease diagnostics market is expected to reach US$ 1503.8 Mn by 2024. Sexually Transmitted Diseases (STDs) segment is expected to continue to remain the largest segment by diseases indication accounting for US$ 282.4 Mn in terms of revenue in 2016, a Y – o – Y increase of 7.0% over 2015. The chlamydia diagnostics test kits are expected to gain upward momentum in 2016, growing at 8.9% in terms of revenue, the fastest among disease indication segment.
Companies
- Becton Dickinson & Company
- Cepheid, Inc.
- Abbott Laboratories
- bioMerieux SA
- Hologic, Inc.
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Roche Diagnostics
- Alera Inc.
- DiaSorin S.p.A.
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- Other
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/11413
Cell cultures segment is expected to register highest CAGR in terms of revenue, by test type accounting for US$ 311.4 Mn in terms of revenue in 2016. The affordability of cell culture kits and large applications in diagnosis of several infectious diseases is gaining traction. Consumption demand for cell culture test kits will witness a growth rate of 7.2 % in 2016 over 2015.
Diagnostic centers end user segment is expected to register highest CAGR in terms of revenue, accounting for US$ 392.8 Mn in terms of revenue in 2016. The increasing number of diagnostics centers, worldwide and a large number of patient pool depending on diagnostics centers for diagnosis of infectious diseases is expected to increase demand for diagnostics tests among diagnostics centers. The diagnostics centers end user segment will witness a growth rate of 7.4 % in 2016 over 2015.
Becton, Dickinson and Company, Cepheid, Inc. Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc. are key players in the market. Top players are focusing on developing new products and improving sensitivity and specificity of the test kits. Collaborations and joint ventures among manufacturers and local governments are key business strategies being adopted to increase market share.
Regional Analysis
Based on the regional analysis, the global infectious disease diagnostics market is segmented into five key regions, North America (the U.S. and Canada), Latin America (Brazil, Mexico, and rest of Latin America), Europe (France, Germany, Italy, Spain, the U.K., Russia, and rest of Europe), Asia Pacific (China, India, Japan, Australia, New Zealand, ASEAN, and rest of APAC), and Middle East & Africa (GCC countries, South Africa, and rest of MEA). APAC and MEA are foreseen to remain the major markets throughout the forecast period.
The APAC market is estimated to account for over 26% share of the total market revenues in 2016, and expand at a CAGR of 7.6% over the forecast period. While governments of various countries in Asia Pacific are increasingly registering higher demand for infectious diseases diagnostic kits resulting in the largest market in this region, the MEA market will also witness a significantly growing market owing to growing governmental initiatives.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/11413
Key Questions Answered in This Report.
- What are the Roadblocks for Infectious Diseases Diagnostics Market Suppliers?
- What are the Key Opportunities for Infectious Diseases Diagnostics Market Manufacturers?
- How is Focus on Safety Influencing Infectious Diseases Diagnostics Market Demand?
- What is the Regulatory Impact on Global Sales of Infectious Diseases Diagnostics Market?
- Which Region Offers the Largest Opportunity for Sales of Infectious Diseases Diagnostics Market?
- Where Does the U.S. Stand in the Market for Infectious Diseases Diagnostics Market?
- What Is the Outlook for Infectious Diseases Diagnostics Market Manufacturers in China?
- Why is Germany a Lucrative Market for Infectious Diseases Diagnostics Market Manufacturers?
- Why Will Belgium Outpace Other European Markets for Infectious Diseases Diagnostics Market?
- Why is There High Demand for Tires in Infectious Diseases Diagnostics Market?
- Why are Sales of Infectious Diseases Diagnostics Market Surging?
TOP Market Research Report:
Animal Stem Cell Therapy Market
Myoelectric Prosthetics Market
E-Clinical Solution Software Market
Neurovascular Thrombectomy Devices Market
Veterinary Molecular Diagnostics Market
Clinical Chemistry Kits Market
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]